Date |
Company |
Amount |
Funding type |
Investors |
Therapeutic area |
Type of Information |
2014-04-07 |
Absolute Antibody (UK) |
£850K ($1.4M - €1.02 million) |
grant |
Technology Strategy Board (UK) and business angels |
|
Grant |
2014-04-07 |
Genomic Vision (France) |
€23 million |
IPO |
|
Diagnostic - Cancer - Oncology |
IPO |
2014-04-04 |
Molmed (Italy) |
€ 4.969 million |
private placement |
Fininvest (Italy) Airain Lda (Italy) H-Equity (USA) |
Cancer - Oncology |
Private placement |
2014-04-03 |
Genticel (France) |
€34.5 million |
IPO |
Edmond de Rotschild Investment Partners (France), Amundi Private Equity Funds (France), BpiFrance (France), Wellington Partners (USA), IRDI (France) |
Infectious diseases - Gynecology - Women's health |
IPO |
2014-03-28 |
Oncodesign (France) |
€ 12.8 million |
IPO |
|
Cancer - Oncology |
IPO |
2014-03-28 |
Aelis Farma (France) |
€1.3 million |
seed financing |
Inserm Transfert Initiative (France) Aqui Invest (France) Aquitaine Création Investissement (France) |
|
Financing round |
2014-03-25 |
Cellectis (France) |
€20.5 million |
private placement |
OrbiMed Advisors (USA), venBio (USA), Ridgeback Capital Management (USA), Aquilo Capital Management (USA), Merlin Nexus (USA) |
Cancer - Oncology |
Private placement |
2014-03-25 |
Adaptimmune (UK) |
£2.1 million (€2.5 million) |
grant |
Biomedical Catalyst Fund (UK) |
Cancer - Oncology |
Grant |
2014-03-24 |
Transgene (France) |
€65.5 million |
capital increase |
|
Cancer - Oncology - Infectious diseases |
Capital increase |
2014-03-24 |
CAP-CMV (Germany) |
€ 1.7 million |
series A financing round |
Peppermint Venture Partners (PVP) (Germany), NRW.Bank (Germany), Creathor Venture (Germany), KfW (Germany), private investors |
Infectious diseases |
Series A financing round |
2014-03-20 |
Nanobiotix (France) |
€ 28.1 million |
private placement |
|
Cancer - Oncology |
Private placement |
2014-03-20 |
Saniona (Denmark) |
SEK 17 million ($2.64 million - €1.92 million) |
IPO |
|
Autoimmune diseases - CNS diseases |
IPO |
2014-03-17 |
Karo Bio (Sweden) |
1 million SEK (€0.11 million) |
grant |
Vinnova (Sweden) |
Cancer - Oncology |
Grant |
2014-03-14 |
Inotrem (France) |
€18 million |
series A financing round |
Edmond de Rotschild Investment Partners (France) Sofinnova Partners (France) Biomed Invest (Switzerland) Inserm Transfert Initiative (France) |
Inflammatory diseases |
Series A financing round |
2014-03-13 |
Circassia (UK) |
£200 million (€238 million) |
IPO |
|
Allergic diseases - Immunological diseases |
IPO |
2014-03-13 |
Vectura (UK) |
£52.0 million (€62.1 million) |
|
|
Inflammatory diseases - Respiratory diseases |
Private placement |
2014-03-07 |
BiolineRx (Israel) |
$24.1 Million (€17.4 million) |
public offering of shares |
|
|
Private placement |
2014-03-06 |
Verona Pharma (UK) |
£14.0 million (€16.8 million) |
private placement |
|
|
|
2014-03-04 |
Summit (UK) |
£22.0 million (€26.7 million) |
private placement |
|
|
Establishment of a new subsidiary in the EU |
2014-02-28 |
Compugen (Israel) |
$72.5 million |
|
|
|
Private placement |